William Blair & Company
SANA icon

William Blair & Company’s Sana Biotechnology SANA Stock Holding History

William Blair & Company’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.6K Buy
28,263
+835
+3% +$2.69K ﹤0.01% 1686
2026
Q1 		$79K Buy
+27,428
New +$108K ﹤0.01% 1634

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

William Blair & Company's SANA Position: Q2 2026 in Review

William Blair & Company increased its Sana Biotechnology (SANA) stake by 3% in Q2 2026, buying an estimated $2.69K and bringing the position to 28,263 shares worth $98.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

William Blair & Company first reported a position in SANA in Q1 2026 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • William Blair & Company held 28,263 shares of Sana Biotechnology worth $98.6K as of Q2 2026.
  • William Blair & Company bought 835 Sana Biotechnology shares in Q2 2026, an estimated $2.69K.
  • Sana Biotechnology made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1686 holding.
  • William Blair & Company first reported a position in Sana Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.